Hospital – Wound Treatment: Trionic (Europe) Algoderm Trionic (Japan)
Hospital Products: Trionic
Bioactive Medical Device for Wound Therapy and Haemostasis
A Class III Product (Medical Device European regulation) Suitable for deep wounds that reach the bone.
Embedded in a hydroactive biopolymer matrix, Mn, Zn, and Ca ions accelerate biological wound healing processes in all phases.
Important enzyme co-factors are released in a controlled manner via ion exchange and migrate into cells involved in tissue regeneration.
Effective stimulation of blood clotting and wound healing.
Bioactive Class III Medical Device for Wound Therapy and Haemostasis
Cell-active effects in all phases of wound healing.
Proven Biological Effects
Trionic activates cells by providing manganese, zinc, and calcium at the cellular level. These crucial enzyme co-factors are released in a controlled manner through ion exchange and migrate into cells involved in tissue regeneration.
- Trionic increases fibroblast density by 50%*.
- Trionic increases collagen production (Type III) by 400%*.
- Trionic increases collagen production (Type I) by 300%*.
Three components create haemostatic action:
- Ca (coagulation factor IV) accelerates platelet aggregation.
- The 3D fibre structure promotes platelet activation.
- The TRIONIC® alginate matrix enhances coagulation.
Indications:
Chronic wounds (e.g., diabetic foot, pressure sores, leg ulcers), traumatically caused wounds (e.g., intra- and postoperative bleeding, burns, surgical wounds), deep wounds, and wound cavities.
Available in four sizes:
TRIONIC 5 cm x 5 cm (TRI 300)
TRIONIC 9.5 cm x 9.5 cm (TRI 301)
TRIONIC 10 cm x 20 cm (TRI 302)
TRIONIC Wound Tamponade 30 cm (TRI 303)
Data on file. Chief Medical Approval in Austria. * MiGel No.